Scythian Biosciences Corp.
(TSXV: $SCYB.V) Applies for Listing of Common Stock on NASDAQ
TORONTO
- August 30, 2017 (Investorideas.com Newswire) Scythian Biosciences Corp. (TSXV: SCYB) (the "Company") is pleased to
announce that it has submitted an initial listing application to list its
common shares on the NASDAQ Capital Market.
The
Company's common shares have traded on the TSX Venture Exchange (the
"TSXV") under the symbol "SCYB" since August 8, 2017.
Read this news in
full at http://www.investorideas.com/CO/SCYB/news/2017/08301NASDAQ.asp
is
a Featured biotech and marijuana company on Investorideas.com
Disclaimer/Disclosure: Investorideas.com
is a digital publisher of third party sourced news, articles and equity
research as well as creates original content, including video, interviews and
articles. Original content created by investorideas is protected by copyright
laws other than syndication rights. Our site does not make recommendations for
purchases or sale of stocks, services or products. Nothing on our sites should
be construed as an offer or solicitation to buy or sell products or securities.
All investment involves risk and possible loss of investment. This site is
currently compensated for news publication and distribution, social media and
marketing, content creation and more. Contact each company directly regarding
content and press release questions. Disclosure is posted for each compensated
news release, content published /created if required but otherwise the news was
not compensated for and was published for the sole interest of our readers and
followers. More disclaimer info: http://www.investorideas.com/About/Disclaimer.asp.
Scythian
Biosciences Corp. (SCYB) is a paid featured company on the 420 Cannabis
Investor Ideas Directory and is a paid featured cannabis company and biotech
for news, social media and PR effective August 7th for 2 months. More details
- http://www.investorideas.com/About/News/Clientspecifics.asp
Additional
info regarding BC Residents and global Investors: Effective September 15 2008 -
all BC investors should review all OTC and Pink sheet listed companies for
adherence in new disclosure filings and filing appropriate documents with
Sedar. Read for more info: http://www.bcsc.bc.ca/release.aspx?id=6894. Global investors
must adhere to regulations of each country